All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 193 of 206 pages ‹ First < 191 192 193 194 195 > Last ›
HSL3424
Fisherow WB.
The shape of prescription drug advertising: a survey of promotional techniques and regulatory trends
Food Drug Cosmetic Law Journal 1987;42:213-236
HSL3425
Freeman JW, Kaatz B.
The physician and the pharmaceutical detail man: an ethical analysis
Journal of Medical Humanities and Bioethics 1987;8:34-39
HSL3426
Gluck ME, Blumenthal D, Stoto MA.
University-industry relationships in life sciences: Implications for students and post-doctoral fellows
Research Policy 1987;16:327-336
HSL3430
Gray BV.
Drug promotion
New Zealand Medical Journal 1987;100:754
HSL3431
Greenhalgh T.
Drug prescription and self-medication in India: an exploratory survey.
Soc Sci Med 1987;25:(3):307-18
HSL3433
Hancher L.
Regulating drug promotion: the UK experience
Journal of Consumer Policy 1987;10:383-407
HSL3439
Hutcheon L, Hutcheon M.
Medical “mythologies”: a semiotic approach to pharmaceutical marketing
Queen’s Quarterly 1987;94:(4):904-916
HSL3440
Johnstone JM.
Special problems in direct-to-consumer advertising of prescription drugs
Food Drug Cosmetic Law Journal 1987;42:315-322
HSL3451
Lexchin J.
Pharmaceutical promotion in Canada: convince them or confuse them.
Int J Health Serv 1987;17:(1):77-89
HSL3452
Lidstone J.
Marketing planning for the pharmaceutical industry
1987;
HSL3453
Mahady JM.
Frequent-flyer programs for drug prescribing
New England Journal of Medicine 1987;317:252
HSL3455
Moulds RF, Wing IM, Shenfield GM, Day RO.
Drug advertising
Medical Journal of Australia 1987;147:160
HSL3456
Palmer WH, Ross DL.
Introducing a new drug into your practice
Canadian Family Physician 1987;33:2529-2533
HSL3457
Perri M, Dickson WM.
Direct to consumer prescription drug advertising: consumer attitudes and physician reaction
Journal of Pharmaceutical Marketing & Management 1987;2:(1):3-25
HSL3458
Roberts WC.
Some realities of present-day cardiologic journal publishing in the USA.
Cardiology 1987;74:(4):254-62
HSL3462
Singleton SW.
Promoting Retrovir
New England Journal of Medicine 1987;317:1160
HSL3463
Smith R.
In delicto flagrante
Medical Journal of Australia 1987;146:322-323
HSL3464
Smith RN.
Role of the pharmaceutical industry in major clinical trials
Lancet 1987;2:1464
HSL3467
Squires BP.
In whose service?
Canadian Medical Association Journal 1987;137:983
HSL3469
Szuba TJ.
Drug promotion under the magnifying glass
Journal of Social and Administrative Pharmacy 1987;4:77-80
HSL3471
Vere DW.
Advertising claims and the Medicines Act
Lancet 1987;1:278
HSL3472
Wall DW.
Ethics and the pharmaceutical industry: some ideas for general practitioners
Journal of the Royal College of General Practitioners 1987;37:267-269
HSL3475
Weston-davies WH.
Advertising claims and the Medicines Act
Lancet 1987;1:278
HSL3477
Wolffers I.
Drug information and sale practices in some pharmacies of Colombo, Sri Lanka.
Soc Sci Med 1987;25:(3):319-21
HSL3478
Yellin AK.
FDA prescription drug enforcement policies and techniques
Food Drug Cosmetic Law Journal 1987;42:552-558
HSL3521
Tucker GK, Smith MC.
Direct-to-consumer advertising: Effects of different formats of warning information disclosure on cognitive reactions of adults
Journal of Pharmaceutical Marketing & Management 1987;2:(1):27-41
HSL9589
Baum C, Faich GA, Anello C, Forbes MB.
Differences in manufacturer reporting of adverse drug reactions to the FDA in 1984
Drug Information Journal 1987;21:(3):257-266
HSL16715
Wolfe S
Letter to the Editor on Suprofen-induced flank pain and renal failure.
NEJM 1987;316:1025
HSL16716
Wolfe S
Dangerous Delays in Tampon Absorbency Warnings
JAMA 1987;258:949
HSL3410
Griffin JP.
Conduct of research on amrinone.
Lancet 1986 Dec 20-27;2:(8521-22):1462
HSL9615
White JP.
New prescription product lineup looking awesome
Drug Topics 1986 Dec 15;130:65-66, 68
HSL3339
Evans KR, Beltramini RF.
Physician acquisition of prescription drug information.
J Health Care Mark 1986 Dec;6:(4):15-25
HSL3408
Re: the promotion of amidopyrine/phenylbutazone/prednisolone
1986 Dec;
HSL3382
Wilmshurst P.
Policing the drug industry.
Lancet 1986 Nov 29;2:(8518):1280-1
HSL9626
Anderson HJ.
More physicians dispensing commonly prescribed drugs.
Mod Healthc 1986 Nov 21;16:(24):46
HSL9616
Robinson B.
Diversion bill derailed by sampling controversy
Drug Topics 1986 Nov 3;130:68
HSL3403
Doctors and the drug industry [Editor's response to 3rd letter (O'Dowd & Whibley)]
British Medical Journal 1986 Nov 1;293:1171
HSL3404
Fakes RW.
Doctors and the drug industry [2nd of 4 letters]
British Medical Journal 1986 Nov 1;293:1170-1171
HSL3405
Lenox-smith I, Clifford JM.
Doctors and the drug industry [4th of 4 letters]
British Medical Journal 1986 Nov 1;293:1171
HSL3406
O'Dowd TC, Whibley R.
Doctors and the drug industry [3rd of 4 letters]
British Medical Journal 1986 Nov 1;293:1171
HSL3407
Wilkie CE.
Doctors and the drug industry [1st of 4 letters]
British Medical Journal 1986 Nov 1;293:1170
HSL3400
MLAM letter follow up—Pfizer
MLAM Newsletter 1986 Nov;
HSL3401
Re: the promotion of arsenic/strychnine
1986 Nov;
HSL3402
Ford AR.
“When women outlive their ovaries”
New Internationalist 1986 Nov;(165):12-13
HSL9618
Colombini A.
Health advertising
Notiz Chim Farm 1986 Nov;25:15
HSL9624
Wade RC.
Promotional group sessions: focus groups that sell
Pharmaceutical Executive 1986 Nov;6:32, 34
HSL3319
Where to draw the line.
Lancet. 1986 Oct 11;2:(8511):849
HSL3374
Smith R.
Doctors and the drug industry: too close for comfort.
Br Med J (Clin Res Ed) 1986 Oct 11;293:(6552):905-6
HSL9605
Weiss B.
What's the FTC up to? State boards want to know!
Drug Topics 1986 Oct 6;130:32, 34
HSL3371
The relationship between physicians and the pharmaceutical industry: A report of the Royal College of Physicians.
J R Coll Physicians Lond 1986 Oct;20:(4):235-42
HSL3397
MLAM letter follow up—Parke Davis/Warner Lambert
MLAM Newsletter 1986 Oct;
HSL3398
Re: the promotion of oral streptomycin/chloramphenicol combination
1986 Oct;
HSL3399
Greenhalgh T.
Beneath cosmetic reforms
HAI News 1986 Oct;
HSL9625
Saks DF.
Today's trends to spur drug industry growth
US Pharmacist 1986 Oct;11:12-16, 20-22
HSL14671
Kissane K.
Drug firm's offer to doctors under fire
National Times 1986 Sep 28
HSL9627
Robinson B.
Dingell keeps fuse burning on sampling practices bomb
Drug Topics 1986 Sep 1;130:28-29
HSL9628
Weiss B.
Bar codes are here: Burroughs Wellcome makes first move
Drug Topics 1986 Sep 1;130:72
HSL3394
Re: the promotion of amrinone
1986 Sep;
HSL3395
Re: the promotion of furazolidone/kaolin/pectin
1986 Sep;
HSL3396
Lexchin J.
Good health?
New Outlook 1986 Sep-Oct;24-26, 28-31
HSL9599
Robbins J.
Pharmacy affairs: making the marketing connection
Pharmaceutical Executive 1986 Sep;6:40, 42, 44
HSL9622
Seltzer SM.
Electronic bulletin boards for RPh's will proliferate
American Druggist 1986 Sep;194:116, 119
HSL9633
Unfair sales act upheld
National Association of Retail Druggists Journal 1986 Sep;108:36-40
HSL9635
Vitriolic anti-generic campaigns held unwarranted
American Pharmacy 1986 Sep;26:16-17
HSL9621
Smith GT.
Use of generic medicines and importance of brand names. Part 2. Importance of brand names for pharmaceutical innovation
Pharmaceutical Journal 1986 Aug 30;237:242-243
HSL3366
Musher DM, Young EJ, Hamill RJ.
The ethics of pharmaceutical promotion.
N Engl J Med 1986 Aug 28;315:(9):590
HSL3344
Holmes J, Hornblow A, Logan W, Botting C, Wells E, Tan SP, Chetwynd J, Frampton C.
Offensive advertising?
N Z Med J 1986 Aug 27;99:(808):641-2
HSL3379
Taylor D.
Effects of medical research on life expectancy.
Lancet 1986 Aug 16;2:(8503):399-400
HSL3377
St George D.
Life expectancy, truth, and the ABPI.
Lancet 1986 Aug 9;2:(8502):346
HSL3365
Moulds RF, Bochner F, Wing LM.
Drug advertising.
Med J Aust 1986 Aug 4-18;145:(3-4):178-9
HSL9631
Robinson B.
Industry moves to control its own sampling destiny
Drug Topics 1986 Aug 4;130:22
HSL3392
Re: the promotion of piroxicam
1986 Aug;
HSL3393
Shugar GS.
Mixed opinions on direct-to-consumer advertising
Medical Marketing & Media 1986 Aug;21:(8):36-38, 40-41
HSL9630
Shugar GR.
Mixed opinions on direct-to-consumer advertising
Medical Marketing and Media 1986 Aug;21:37-38, 40-41
HSL9634
Davis DA.
FDA becoming sensitive to anti-generic campaign
Drug Cosmet Ind 1986 Aug;139:30, 32, 35
HSL9637
Hadeler F.
Should expiration dates be required on patients' prescription labels?
Am Pharm 1986 Aug;NS26:(8):30-5
HSL9640
De-mino L.
How Peoples Drug chain helps patrons take medicines properly
Pharmacy Times 1986 Aug;52:36-38
HSL9611
Harvey KJ, Stewart R, Hemming M, Naismith N, Moulds RF.
Educational antibiotic advertising.
Med J Aust 1986 Jul 7;145:(1):28-32
HSL3390
Re: the promotion of diphenhydramine and ammonium chloride
1986 Jul;
HSL3391
Pierpaoli PG.
ASHP's position on direct-to-consumer advertising of prescription drug products.
Am J Hosp Pharm 1986 Jul;43:(7):1763-5
HSL9641
Programmed-delivery products revitalize markets for old drugs, report says
American Journal of Hospital Pharmacy 1986 Jul;43:1645-1646
HSL9643
Commodity generic sales in 1985 grew 50% over 1984, says report on generic drug industry
American Journal of Hospital Pharmacy 1986 Jul;43:1644
HSL9648
Concerning the case of: United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association, Civil No. G75-558 CA5, W.D. Michigan
Journal Michigan Pharmacist 1986 Jul;24:14-15
HSL3341
Greenhalgh T.
Drug marketing in the Third World: beneath the cosmetic reforms.
Lancet 1986 Jun 7;1:(8493):1318-20
HSL9639
Cusick JJ, Downs GE.
Prescription to over-the-counter switch
American Druggist 1986 Jun;193:101-107, 113
HSL9642
McCarthy R.
Dingell subcommittee would ban physical sampling
American Druggist 1986 Jun;193:12, 17
HSL20477
Haslam A
Doctor on warpath
New Sunday Times 1986 May 4
HSL3337
Davidson RA.
Source of funding and outcome of clinical trials.
J Gen Intern Med 1986 May-Jun;1:(3):155-8
HSL9629
Lord R.
Reye's syndrome and aspirin-industry's position
Australian Journal of Pharmacy 1986 May;67:518, 520, 522
HSL9654
Cardinale V.
Industry leaders extend hand in fair pricing
Drug Topics 1986 Apr 21;130:18, 20, 22
HSL3359
McCue JD, Hansen CJ, Gal P.
Physicians' opinions of the accuracy, accessibility, and frequency of use of ten sources of new drug information.
South Med J 1986 Apr;79:(4):441-3
HSL3388
Re: the promotion of Rheopyrine
1986 Apr;
HSL9623
Woodhouse RJ.
UK prescribing limits begin to take toll
Drug Cosmet Ind 1986 Apr;138:50, 52, 104-105
HSL9647
FDA speaks out about generic drug quality
National Association of Boards of Pharmacy Newsletter 1986 Apr;15:53-54
HSL9651
Commerce Department predicts gains in pharmacist prescribing
American Pharmacy 1986 Apr;26:20
HSL9655
Mossinghoff GJ.
Drug price increase explained.
Am Pharm 1986 Apr;NS26:(4):5-6
HSL9646
Drug search: meshing costs, regs
Medical World News 1986 Mar 10;27:114-115
HSL3375
Spiro HM.
Mammon and medicine. The rewards of clinical trials
JAMA. 1986 Mar 7;255(9):1174-5 1986 Mar 07;255:(9):1174-5
HSL3386
Re: the promotion of Primobolan and Fortabol
1986 Mar;
HSL3387
To what extent should pharmaceutical houses advertise to the public?
Pharmacy Times 1986 Mar;52:(3):86-88, 90, 93
Page 193 of 206 pages ‹ First < 191 192 193 194 195 > Last ›
